Scientists made a healthy diet using highly processed foods

Scientists made a healthy diet using highly processed foods

Comments 0 Comment

The USDA has created a seven-day nutritionally balanced meal plan that is experimental and almost entirely made up of ultra-processed foods. However, a variety of ultra-processed meals have been strongly associated with long-term health problems.

The diet that scientists devised also fell short in terms of providing essential nutrients like vitamins D and E. Unresolved is the question of what constitutes “ultra-processed” food.

American consumption of industrially produced food has increased over the past 20 years, rising from 53.5% of daily calories in 2001 and 2002 to 57% in 2017 and 2018. Many people refer to these items as “ultra-processed foods,” or “UPF.”

These foods may not give enough nutrients because they were created for flavour, affordability, and an extended shelf life, which is connected to chronic diseases.

Nutritional research scientists at the United States Department of Agriculture (USDA) were interested to find out if a person could adhere to the Dietary Guidelines for Americans (DGA) solely from UPF. A proof-of-concept seven-day menu has been shown in a study that the researchers have published.

The menu received an overall score of 86 out of 100 on the Healthy Eating Index (HEI), with 91% of the diet’s calories coming from UPF. It only fell short on two nutritional fronts: salt content and whole grains.

The average American diet only receives a score of 59 on the HEI, in contrast. The menu is an experiment and a case study of the adaptability of DGA recommendations; it is not a real suggested meal plan.

The researchers modified the MyPyramid menu to create their meal in accordance with present dietary recommendations.

The press statement presenting the findings emphasises that additional research is required because existing dietary recommendations are more concentrated on nutritional content than the level or kind of processing involved.

What foods are ‘ultra-processed’?

Determining what UPF are, according to study lead author Dr. Julie M. Hess, a researcher at the USDA’s Grand Forks Human Nutrition Research Centre, is one of the challenges with assessing them.

Our research revealed that several nutrient-rich items, including whole wheat bread, nonfat milk, canned fruit, tofu, fruit juice, and canned fish, might be categorized as ultra-processed.

The researchers worked with outside “graders” who assigned grades to the meals under evaluation based on how processed they were.

“Some of the foods that our graders considered ‘ultra-processed’ that did not end up on our menu were: almond butter, pork loin, smoked oysters, soy milk, cottage cheese, nonfat Greek yogurt, lactose-free milk, and apple juice,” explained Dr. Hess.

Black bean soup, porridge, a baked potato with chilli, tofu stir fry and a steak supper were some of the dishes on the menu. We left out canned mushrooms, canned peas, and applesauce from our menu since our graders thought they were less processed.

A plant-based “meat” burger, pickles, banana chips, sesame sticks, and other things that the researchers thought did not fall into a DNA category were also not taken into account.

Unanticipated foods

“It is also important to note that nutrient-dense foods like beans and legumes, for example, can be considered ultra-processed due to the citric acid or additives added to preserve it,” said Michelle Rothstein, a cardiology nutritionist who was not involved in the study. Even if they are believed to be highly processed, they yet provide health benefits that we must also consider in the overall scheme of things.

“Until the scientific community identifies more precisely what the term ‘ultra-processed’ means, it will not be possible to determine whether ultra-processed foods are healthy or not,” said Dr. Julie M. Hess.

Why a meal plan high in processed foods was developed?

Dr. Hess’ team constructed the experimental menu in accordance with the NOVA system, the most widely utilised system for identifying ultra-processed foods, knowing that the 2025 DGA scientific committee will be talking about UPF.

Dr. Hess said, “My research focuses on discovering and assessing solutions to assist Americans in following recommendations from the Dietary Guidelines for Americans, which means I monitor carefully the activities and conversation linked to the formulation of dietary guidance in the U.S.”

Routhenstein voiced concern that most people lack the nutritional knowledge needed to create the menu.

Rosenstein additionally questioned the realism of some menu selections. As an illustration, strawberry kefir might contain xanthan gum, which is currently regarded as ultra-processed. They are receiving honey-roasted chickpeas with an ingredient that is currently regarded as ultra-processed.

It’s crucial to meet people where they are, she added, and this might be a useful learning tool depending on what’s available.

Routhenstein argued that “This is not an accurate depiction of what is actually available to a person who relies on ultra-processed foods, that would not be available in a low-income neighbourhood.”

Potential risks of highly processed meals

Even if UPFs aren’t well defined, there are plenty of worries about how eating food that has been popularly deemed ultra-processed would affect our health.

In addition to not participating in the study, Dr. Marialaura Bonaccio of the IRCCS Istituto Neurologico Mediterraneo Neuromed in Italy stated that “the well-documented adverse health effects of UPF are not exclusively related to the poor nutritional content of these foods, but are likely triggered by non-nutritional factors, such as food additives, contaminants from plastics, alteration to the food matrix, etc.”

Dr. Bonaccio cited a study of her own in which these issues are covered. According to Rosenstein’s analysis of Dr. Bonaccio’s research, consuming more UPF in one’s diet was linked to an increase in cardiovascular disease and all-cause death.

According to certain research, “UPF is independently associated with e.g., mortality cardiovascular disease, and certain cancers,” claimed Dr. Bonaccio.

Such health impacts were outside the purview of this study. However, Routhenstein issued a warning: “Ultra-processed foods produce an increase in cystatin c, an inflammatory biomarker that raises risk of heart disease, kidney disease, and stroke, regardless of whether they are following a vegan, vegetarian diet, etc.

Dr. Bonaccio stated, “In light of this, I believe that a work exclusively focused on the nutritional quality of UPF, which of course could also be adequate in some cases, is completely misleading.”

Even though Dr. Hess claimed “There is not a consistent or easy to apply definition of what a ‘ultra-processed’ food is,” Drs. Bonaccio and Routhenstein advised individuals to limit their use of ultra-processed meals until more evidence is available.

REFERENCES:

For Alzheimer’s disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=83

Melanoma: Black man at 26% higher risk to die.

Melanoma: Black man at 26% higher risk to die.

Comments 0 Comment

Significant melanoma discrepancies between racial and ethnic groupings have been discovered by researchers.

Using the National Cancer Database, researchers discovered that Black males had the lowest survival rates for melanoma diagnoses and a 26% higher mortality risk than white men.

Put on sun-protective clothing, use sunscreen, and examine your skin once a month to protect yourself from melanoma.

While there are many studies on both male and female melanoma instances, there is little information on how race affects this skin disease, particularly in men.

A group of experts looked over the National Cancer Database to find out more. They looked at male non-Hispanic white, non-Hispanic black, non-Hispanic Asian, non-Hispanic American Indian/Alaska Native instances of primary cutaneous invasive melanoma.

Their data showed melanoma incidence differences between racial and ethnic groupings.

The trunk was the most typical site for melanoma in both white people and American Indian/Alaskan Native people. Men of color Black, Asian, and Hispanic had their lower extremities found to have melanoma, though.

The majority of stage 3 or stage 4 melanomas (48.6%) were seen in Black people. White guys (75.1%) and Black males (51.7%) had the highest 5-year overall melanoma survival rates.

According to research, black people with melanoma had a 26% higher mortality rate than white people with the same diagnosis.

Dr. Bianka Bubic, study author and a dermatology research fellow at The Ohio State University Wexner Medical Centre, said, “We hope that this study lays the foundation for future research to explore the reasons for why there are different presentations and survival among men of diverse racial groups in melanoma.”

Survival rates for melanoma vary by race

Researchers are currently looking into why Black people have a higher chance of developing severe melanoma. Pigmented lesions that may have variations in size, form, symmetry, or pattern can be early indicators of melanoma.

A board-certified dermatologist at Psoriasis Telehealth in Palo Alto, California, Dr. Faranak Kamangar, told that early detection of skin abnormalities in the Black community may be more challenging, thus postponing diagnosis.

She pointed out that the results emphasise the value of early cancer screening in many racial and ethnic groups.

Dr. Kamanger pointed out that socioeconomic issues such a lack of cheap insurance and medical treatment may disproportionately affect the severity of melanoma in Black communities, which could result in a diagnosis at a late stage.

“The main tendency, that Black men are diagnosed with melanoma at later stages, making it less likely to be treated and probably leading to greater rates of morbidity and mortality for this population, has been known to us for some time. The research also confirms previously reported findings that Black men are more likely to develop acral lentiginous melanoma, a subtype of melanoma that is typically detected at a later stage and may occur in difficult-to-examine body regions. Bob Marley is a well-known illustration. He unfortunately had a late diagnosis of melanoma and passed away from it,” according to board-certified dermatologist Dr. Faranak Kamangar.

Acral lentiginous melanoma is the most prevalent melanoma subtype in Black people, but it is also more challenging to identify and diagnose early.

Dr. Wael Harb, a haematologist and medical oncologist at MemorialCare Cancer Institute at Orange Coast Medical Centre in Fountain Valley, California, said that acral lentiginous melanoma “typically appears on less noticeable or examined areas like the palms, soles, or under the nails.”

Are there genetic factors that influence melanoma risk?

Racial and ethnic inequalities in melanoma risk may also be influenced by genetics.

According to Dr. Kamanger, “Acral lentiginous melanoma has higher rates in this population due to genetic predispositions and, in general, is diagnosed at a later stage.”

We have now discovered genes that predispose to acral lentiginous melanoma, and this is the key factor contributing to greater risk among some groups. Diagnosis may be delayed if the nails and bottom of the feet are involved. Except for the amelanotic subtype, melanoma is often pigmented and brown in colour, according to Dr. Kamanger.

Dr. Harb emphasised that acral lentiginous melanoma frequently manifests in locations that are not as exposed to the sun. This may explain why certain body parts, such as the palms, soles, and areas under the nails, are particularly vulnerable.

Dr. Harb noted that “this type of melanoma frequently develops in areas with less melanin, which provides natural protection against UV damage.”

Dr. Harb contrasted this with the development of superficial spreading melanoma, which frequently appears as a new or changing mole or discoloured area on sun-exposed skin.

The different ways that melanoma manifests in Black and White people emphasizes the significance of thorough skin inspections that include all body parts, not just those that are regularly exposed to the sun.

Research on the prevalence of melanoma in various racial groups is still lacking.

The majority of research papers conducted so far focus on white people’s melanoma cases. Dr. Kamanger noted that as a result, the conclusions that may be drawn are limited by the tiny sample size of Black men.

The primary flaw with this study is that Black men make up less than 0.5% of the population. To obtain useful sub-data, this is a very small quantity, as Dr. Kamanger pointed out.

“The study has some limitations, even if it offers insightful information. It does not take into consideration disease-specific survival, which limits our capacity to distinguish between melanoma mortality and death from other causes,” according to Dr. Harb.

Additionally, certain data were missing, which may have impacted the precision and thoroughness of the findings.

Additionally, compared to white people, there were significantly fewer instances of melanoma among ethnic minority groups. Dr. Harb continued that this can result in bias because the sample might not accurately reflect the entire population.

Taking steps to prevent melanoma

The first step in preventing skin cancer is to shield yourself from the sun. There is no safe level of ultraviolet light exposure, according to Dr. Kamanger, who described ultraviolet light as a real carcinogen.

“UPF clothing, SPF 30 and above sun protection, and seeking shade should be practised.”

Every part of your body, including your feet and nails, should be examined once a month, according to Dr. Kamanger.

When in doubt, schedule a yearly skin cancer test with a board-certified dermatologist, said Dr. Kamanger.

According to Dr. Bubic, “any lesions that may be changing, increasing in size, bleeding, or not healing appropriately should be evaluated.”

REFERENCES:

For Alzheimer’s disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=10

CRISPR gene therapy: Can it cure Alzheimer’s disease?

CRISPR gene therapy: Can it cure Alzheimer’s disease?

Comments 0 Comment

During the Alzheimer’s Association International Conference (AAIC) 2023 in Amsterdam, two cutting-edge CRISPR-based therapy strategies for Alzheimer’s disease were disclosed.

One strategy is to lessen the impact of the APOE-e4 gene, a substantial genetic risk factor for Alzheimer’s. The second strategy is to lessen the amount of beta-amyloid, a damaging protein linked to the illness.

These innovations offer hope to people who are impacted by Alzheimer’s and have the potential to advance treatment options.

Scientists modify genes using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) mechanism. Similar to a pair of tiny molecular scissors, CRISPR makes a precise cut in a particular spot in a DNA sequence.

Once the DNA has been sliced, researchers can eliminate undesirable genes, replace defective genes with healthy ones, or even add new genes entirely.

CRISPR has the potential to advance our understanding of genetic disorders, and aid in the creation of fresh therapies. Also, it hastens the discovery of new therapeutic targets and eventually speed up the drug discovery process.

At the Alzheimer’s Association International Conference (AAIC) 2023, which was recently held in Amsterdam, researchers announced two new CRISPR-based therapeutic strategies to cure and prevent Alzheimer’s.

Decreased synthesis of amyloid beta after CRISPR

As part of the initial investigation, scientists at the University of California, San Diego, created a CRISPR-based gene-editing method. It selectively targets the amyloid precursor protein (APP), a key component of Alzheimer’s disease.

The APP gene generates a variety of byproducts, some of which are pathological (beta-amyloid, sAPPa), while others are protective (sAPPa).

This strategy seeks to increase neuroprotective effects while reducing beta-amyloid formation. The researchers experimented on mice with Alzheimer’s disease to see how well their plan worked.

They discovered that beta-amyloid plaques decreased with CRISPR therapy, as did brain inflammatory indicators, and neuroprotective APP products increased. Also, behavioral and nervous system performance improved.

Importantly, CRISPR editing did not have any unfavourable impacts in mice that were in good health.

According to study, lead author Dr. Brent Aulston, a postdoctoral researcher at the Altman Clinical and Translational Research Institute at UC San Diego, “the idea of our therapeutic is to utilize CRISPR to introduce a change in the patient’s genome that is protective against Alzheimer’s disease.”

“So far, we have tried this strategy in rats that exhibit the same disease symptoms as do human Alzheimer’s patients, and we have discovered that our medication lowers disease markers. Additionally, no unfavorable side effects have been noticed,” he added.

Our CRISPR therapy was developed to treat both familial and sporadic varieties of Alzheimer’s disease, according to the authors. Dr. Brent Aulston stated, “We are currently working on transferring this strategy from the lab to the clinic with the hope that our CRISPR-based gene therapy will someday be a treatment option for the illness”.

The APOE gene’s expression may be reduced via CRISPR.

In a different study, a group of scientists from Duke University created a potential therapeutic strategy utilizing CRISPR to target APOE-e4, a genetic risk factor for Alzheimer’s disease.

It is more likely to get Alzheimer’s if you inherit this gene; one copy of APOE-e4 enhances the risk by two to three times, and two copies further magnify the risk by about eight to twelve times.

To reduce the levels of APOE-e4, the researchers used an epigenome treatment platform based on the CRISPR/dCas9-editing technique.

In human induced pluripotent stem cell-derived miniature brains from an Alzheimer’s patient as well as in humanized mice models, their lead candidate showed notable efficacy in lowering APOE-e4 levels.

It’s significant that this strategy had no impact on the levels of other APOE variants thought to have a protective or neutral effect.

The most powerful genetic risk factor for Alzheimer’s is APOE.

As a senior co-author of the study and professor at the Duke University Medical Center’s Alzheimer’s Disease Research Centre and Centre for Genomic and Computational Biology, Dr. Ornit Chiba-Falek stated that they have created this innovative therapeutic platform for Alzheimer’s based on gene editing technology.

“The platform reduces the expression of APOE, the strongest genetic risk factor for Alzheimer’s disease, by closing the genomic region surrounding the gene making it less accessible for the transcriptional machinery,” explained Dr. Chiba-Falek.

“This study provides proof-of-concept for our therapeutic strategy in both human-based cellular and rodent models, demonstrating the efficacy and beneficial effects related to Alzheimer’s pathology,” the researcher continued.

A newly discovered therapeutic target for Alzheimer’s disease is APOE. Dr. Ornit Chiba-Falek stated, “The findings of this study pave the way for gene therapy in Alzheimer’s disease and lay the groundwork for the advancement of this APOE-targeted epigenome therapy towards clinical studies and ultimately precision medicine in Alzheimer’s.”

Proof-of-concept, therefore more study is required

The chief medical officer and CEO of INmune Bio, Raymond J. Tesi, MD, told MNT that “this technology is fascinating and promising.” However, Dr. Tesi noted that at this time, Alzheimer’s disease might not be the optimal condition to use CRISPR.

“Using CRISPR to treat [Alzheimer’s patients] and stop the production of new amyloid is a confused approach. According to what I understand, CRISPR therapy will prevent the creation of amyloid but will not eliminate it for people with [Alzheimer’s]. Is not removing amyloid from the brain the goal of amyloid-targeted therapy? Does eliminating amyloid from the brain have the same advantages as preventing its production? I’m not sure,” he replied.

“Is this outcome sufficient to conduct a clinical trial? To think that stopping more amyloid synthesis will have the same therapeutic advantages as eliminating amyloid from the brain strikes me as naive. Dr. Raymond J. Tesi remarked, “I either need more information or more research on this therapeutic approach.”

Dr. Tesi stated that while thinking about the second strategy, “60% of Alzheimer’s patients exhibit ApoE4. Unfortunately, we are unsure of which ApoE4 patients may ultimately get [the condition].

“In addition, we don’t know what ApoE4 does. In other words, does ApoE4 contribute to the pathology that results in [Alzheimer’s] or does ApoE4 itself contribute to cognitive decline? Before we apply it to humans, in my opinion, more research needs to be done to better understand the impact of’silencing’ ApoE4,” he said.

“I think it’s time to broaden our efforts beyond the amyloid-targeting therapy approaches; we know how effective they are,” Dr. Raymond J. Tesi declared that ApoE4 is an intriguing target that merits more investigation.

There are a lot of other targets worth considering. We favour neuroinflammation and have evidence to back up that therapeutic approach, said Dr. Tesi.

Another aspect to take into account is cost.

Dr. Tesi also emphasised the significance of taking into account cost while planning gene therapies. All currently accessible gene therapies cost millions of dollars.

The lecanemab (Leqembi) community considers its $26,500 annual cost to be prohibitive. Anti-amyloid CRISPR therapies are anticipated to cost significantly more than antibody-based therapies.

Patients, payers, and governments are all impacted by this issue in practice because therapies, especially preventative ones, should be less expensive than treatments.

It will be crucial to strike a balance between the attractiveness of new technology and its actual use.

Ultimately, more research is required because many therapeutic approaches are only at the proof-of-concept stage.

In addition to continuing to research potential treatment targets, it is important to take into account the logistical and financial difficulties involved in actually providing these kinds of therapy.

REFERENCES:

For Alzheimer’s disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=31

Can a daily brief walk could help with depression?

Can a daily brief walk could help with depression?

Comments 0 Comment

Exercise can enhance brain health, lower disease risk, build bones and muscles, and manage weight.

There is mounting evidence that it can also reduce the signs and symptoms of depression, the main disorder connected to mental health. However, opinions on how much exercise is necessary to have a positive impact vary.

Now, a 10-year research in Ireland has discovered that even little quantities of exercise, like a daily 20-minute stroll, can help older persons experience less despair.

Depression, one of the most prevalent mental health illnesses, is characterized by a persistent sense of emptiness, sadness, or an inability to experience a pleasure. The World Health Organisation (WHO) estimates that it affects about 5% of adults globally.

In 2020, there were 21 million individuals in the United States (8.4% of all adults), and women were more likely than males to experience serious depressive episodes.

According to official government figures, one in six adults in the United Kingdom reported having depressed symptoms in 2021–2022.

Depending on the type of depression a person is dealing with, there are several treatments available, such as antidepressants, psychotherapy like cognitive behavioural therapy (CBT), or a combination of therapy and medicine. Many people find them to be helpful, but once treatment is discontinued, depression may recur.

A little exercise can make a big difference.

There is mounting evidence that altering one’s lifestyle helps lessen depression symptoms. A diet rich in fruit, vegetables, seafood, and whole grains may be linked to a lower incidence of depression, according to a 2014 analysis of 21 research. Additionally, a 2022 analysis of studies revealed that exercise reduced the symptoms of depression.

How much exercise is necessary to reduce depression, however, has not been the subject of many studies.

Now, a ten-year study has discovered that even little exercise helps lessen depression in older persons, defined as those who are 50 years of age and older.

The Health Research Board (HRB) Ireland-funded study, which is published in JAMA Network Open, discovered that a 20-minute brisk walk five times a week dramatically decreased the incidence of depression.

The University of Limerick in Ireland’s Dr. Eamon Laird, the study’s author, explained why the group conducted the investigation:

“Unfortunately, depression is becoming more common in older adults and is linked to a higher risk of developing chronic illnesses like cardiovascular disease (CVD), cognitive decline, death, and suicide. Previous studies have linked physical activity to a lower risk of depression, but no one has ever looked into the absolute minimum amount of physical activity that might be beneficial.

Exercise in general lessens depression

The Irish Longitudinal Study on Ageing (TILDA), a sizable longitudinal study with the goal of enhancing Irish citizens’ ageing experiences, provided the researchers with 4,016 participants. They gathered information between October 2009 and December 2018 at five different intervals.

The researchers used self-completed questionnaires, nurse health assessments, or interviews to gather thorough data on demographic, health, lifestyle, and social aspects at each time point.

The Centre for Epidemiological Studies Depression (CES-D) short form was used to evaluate depressive symptoms. Using this information, they defined major depression as either having a CES-D score more than or equal to nine and/or experiencing a major depressive episode at any moment throughout the data collection process.

Participants self-reported their physical activity over the previous seven days at each data point. They were to keep track of the days they engaged in vigorous, moderate, and walking activities as well as the duration of those activities.

After estimating each person’s weekly total of MET minutes, the researchers divided them into three groups based on their level of physical activity: low, moderate, and high.

Dr. Laird informed us, “We found that older adults who engaged in as little as 20 minutes of moderate to vigorous physical activity (MVPA) per day (for five days a week) had a 16% lower risk of depressive symptoms and a 43% lower odds of depression than those engaging in no exercise.”

The benefits grew as the researchers’ exercise levels rose in each of the three exercise categories. The most active people had a 20% lower chance of developing depression than the least active people.

Even individuals who exercised infrequently had a 16% lower risk of depression than those who did not exercise at all.

Exercise, chronic illness, and depression

Dr. Laird noted that exercise reduced the probability of both depressive symptoms and major depression in people with chronic diseases, and that the benefit grew with increased activity levels.

The WHO standards threshold of 30 minutes a day [per] 5 days [a] week for depressed symptoms was met by participants, specifically for those with chronic conditions, albeit the biggest decreases came with increasing exercise dose, according to the study.

He continued, “In essence, those with chronic diseases may find more benefits. It might be several pathways, including anti-inflammatory, immunological function, heart-brain communication, enhanced muscle performance, etc.”

The study’s non-participant, Dr. Thomas MacLaren, a consultant psychiatrist at Re: Cognition Health, applauded the results.

Chronic health conditions are known to worsen depression and may possibly increase one’s likelihood of getting depressed. The study’s conclusion that there was a dose-dependent association for this group is really positive and shows that adding more brisk walking to your daily routine will help you feel better, he said.

The benefits of exercise for mental health.

Exercise may lower the chance of getting depression or lessen depressive symptoms for a number of reasons.

Exercise improves blood flow to the brain, lowers stress reactivity, and stimulates the hypothalamic-pituitary-adrenal (HPA) axis, which affects motivation and mood. Endorphins, the body’s natural pain and stress relievers, are also produced in greater quantities.

As Dr. MacLaren noted, the impacts go beyond the physical.

Exercise raises fitness levels and encourages the body to release endorphins. Your mood can be elevated naturally by these advantageous consequences. Additionally, it may indirectly improve your daily routine and increase social contact, both of which are crucial in the fight against depression.

Dr. Laird concurred, pointing out that for maximum effect, exercise should be a component of a healthy lifestyle.

“Try to incorporate [exercise] into a routine with hobbies or activities that you enjoy, and we would recommend doing it with others as social interactions, particularly with activity, can also have additional benefits for your mental health,” he advised.

“Remember that it is one component and that nutrition and a healthy lifestyle will also give additive benefits in addition to the physical activity,” said Dr. Laird.

REFERENCES:

For Depression medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=77_478

Improve melanoma treatment with fecal transplant?

Improve melanoma treatment with fecal transplant?

Comments 0 Comment

Using immune checkpoint inhibitors like pembrolizumab or nivolumab in conjunction with fecal transplants demonstrated the procedure’s safety in patients with advanced melanoma, according to a phase 1 clinical trial.

65% of the trial participants experienced a favorable response to immunotherapy. Following the fecal transplant, positive responders’ gut microbiomes revealed a rise in helpful bacteria and a decrease in dangerous bacteria.

Larger phase 2 trials will be carried out, and the use of faecal transplants in difficult-to-treat malignancies like pancreatic cancer will be investigated.

Numerous cancer patients have recently benefited from a type of treatment called immunotherapy, which uses the immune systems of the patients to identify and eliminate cancer cells.

Some immunotherapy medications, such as pembrolizumab (Keytruda) and nivolumab (Opdivo), function by preventing the mechanism by which cancer cells can conceal themselves from the immune system.

These immune checkpoint inhibitors, also known as anti-programmed death (PD-1) medications, are successful in treating roughly 50% of patients with melanoma, a kind of skin cancer.

Recently, researchers investigated whether patients with metastatic melanoma might respond better if immunotherapy and fecal microbiota transplants were combined.

This combination was not only risk-free but most patients responded well to the therapy, with some obtaining complete remission.

Phase 1 of the trial

Faecal transplants were coupled with the licenced medications pembrolizumab or nivolumab, which are already the standard of care for advanced melanoma, in the phase 1 MIMic trial.

The objective of the clinical experiment was to determine whether it is secure to combine these two medications in melanoma patients. As a supplementary goal, the impact of faecal transplants on the immune system and gut flora was evaluated.

Following a technique that was approved by Health Canada, healthy donors were carefully chosen. Then, capsules were created using the faeces of healthy donors.

Twenty metastatic melanoma patients were enrolled in the trial from Lawson Health Research Institute, the Jewish General Hospital (JGH), and the Centre Hospitalier de l’Université de Montréal (CRCHUM).

Each research subject was given capsules containing 80–100 mg of a fecal transplant from a single healthy volunteer donor. At least a week before receiving treatment with approved immunotherapy medications (either pembrolizumab or nivolumab), the fecal transplants were administered orally as capsules.

Is fecal transplantation plus immunotherapy safe?

The faecal transplantation operation was successfully completed by each of the 20 patients.

No major side effects were noticed prior to beginning immunotherapy, and no infections were spread through faecal transplantation. However, eight patients (40%) did have mild to moderate side effects from faecal transplantation, including diarrhoea, flatulence, and abdominal discomfort.

17 patients (85%) of the group encountered adverse immune-related events, the majority of which (70%) happened within the first three months of immunotherapy. Of these, five study participants (25%) experienced significant immune-related adverse effects, including nephritis (n = 1), arthritis (n = 2), exhaustion (n = 1), pneumonitis (n = 1), and arthritis (n = 2). These side effects forced the study participants to stop receiving their medication.

The researchers found no previously unreported adverse reactions to immunotherapy or faecal transplantation.

Did combined therapy lead to better results?

Four of the 20 participants in the trial (20%) experienced complete remission, making up 65% (13 out of 20) of the patients who responded favorably to the therapy.

All patients had strains of the donor’s bacteria in their gut microbiomes, according to analysis; however, this resemblance only got stronger over time in those patients who had a good response to the therapy. After receiving faecal transplants, respondents had higher levels of helpful bacteria and lower levels of dangerous bacteria.

The good impact of healthy donor faeces in boosting the efficiency of immunotherapy was further demonstrated in studies on mice by the researchers.

Fecal microbial transplantation: what is it?

Fecal transplantation, also known as fecal microbial transplantation (FMT), is a medical treatment in which the recipient’s intestines are filled with a healthy person’s donated poo (or feces).

In order to address medical disorders linked to abnormalities in gut bacteria, this method involves introducing healthy bacteria into the recipient’s intestines.

The effective treatment for recurrent Clostridium difficile infections is fecal transplantation. Fecal transplants are frequently administered via colonoscopy, however they can also be given as pills.

Gut and immune system interaction

So why do immune checkpoint inhibitors not work for everyone?

Recent research reveals that the bacteria in the gut may have an impact on how well the medications work. Immune checkpoint inhibitor-responsive individuals have a distinctive and healthy gut microbiome, often known as a “group of microorganisms in their gut.”

One of the study’s authors, Saman Maleki, Ph.D., assistant professor of oncology, pathology and laboratory medicine, and medical biophysics at Western University, as well as a researcher at the London Regional Cancer Programme and Lawson Health Research Institute, reasoned that altering a person’s gut microbiome to make it more diverse and healthy may enhance their response to immune checkpoint inhibitors.

Faecal microbial transplantation is one technique to modify the gut microbiota.

Will fecal transplants be used in the management of melanoma?

The principal study investigator, Dr. John Lenehan, a medical oncologist at the London Regional Cancer Programme, an associate scientist at the Lawson Health Research Institute, and an associate professor of family medicine and oncology at Western University, stated that the most significant finding in the study was that “none of the patients were harmed by the experimental treatment.”

Faecal transplants had been demonstrated to be beneficial by observational and pre-clinical studies, but “what happens in mice does not always translate to patients,” he noted. In fact, according to Dr. Lenehan, “more recent studies using similar therapies have shown harm, with patients having a worse response.”

He clarified that faecal transplantation was carried out differently in these other investigations than it was in the MIMic experiment.

“There are several factors, including bowel preparation, the number of FMTs required, the amount of stool required, and the identity of the donors. We had no idea if our approach would be secure or efficient. Thankfully, it appears that it was both! “, he exclaimed.

The director of the Supportive Oncology Research Group at the University of Adelaide and a research fellow at the Hospital Research Foundation Group, Hannah Wardill, Ph.D., who was not involved in this study, thinks this combination therapy strategy has the potential to be a successful treatment.

“FMT is a reasonably accessible intervention, and this study shows it is safe and likely effective at improving immunotherapy response,” she added.

The combination of faecal transplants and immunotherapy results in an improved response rate in patients who would otherwise be unresponsive to immunotherapy, which indicates that “more people will benefit from immunotherapy,” according to Dr. Wardill.

REFERENCES:

For Cancer disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=10

New biomarkers help in sooner diagnosis of ovarian cancer.

New biomarkers help in sooner diagnosis of ovarian cancer.

Comments 0 Comment

In the United States, ovarian cancer ranks as the sixth most frequent cancer among women. A better possibility of successful treatment results from early diagnosis. However, because the symptoms of ovarian cancer sometimes resemble those of digestive problems, it can be challenging to identify.

Three previously unidentified ovarian cancer proteins that can be found in the blood have recently been discovered by new research. These may make it easier to diagnose ovarian cancer, enabling early treatment to begin when it is most likely to be successful.

Any malignant tumor that begins in the ovaries the female reproductive organs located low in the abdomen is considered to be ovarian cancer.

Ovarian cancer rates have declined recently, but it still claims more lives than any other cancer of the female reproductive system. This is according to the Centres for Disease Control and Prevention (CDC).

Ovarian cancer symptoms, which typically manifest in older women, can be confused with those of other gynaecological or digestive conditions since they can include:

  • pelvic pressure or pain
  • abnormal vaginal bleeding
  • back or stomach ache
  • Bloating or the sensation of being full after eating
  • Changes in bowel or bladder habits, such as constipation and more frequent urination.

Early detection of ovarian cancer usually results in good treatment, with 94% of patients living at least five years after diagnosis. However, only 20% of ovarian malignancies are discovered at an early stage, and there are no reliable screening tools available at this time.

Three previously undiscovered membrane proteins that can be extracted from bodily fluids like blood, urine, and saliva have now been linked to ovarian cancer, according to new research led by Nagoya University in Japan.

These results, according to the study’s authors, could result in an earlier detection of ovarian cancer, according to Science Advances.

Various ovarian cancer tumor types?

Ovarian tumours can be of three primary types:

Epithelial tumors. The cells that make up these tumours come from the ovary’s outer layer. The majority of ovarian tumours are epithelial tumours, according to the American Cancer Society. Typically, women over 50 are diagnosed with these tumours.

Stromal tumours. Cells of structural tissue are where stromal tumours start. In addition, progesterone and oestrogen are produced by these cells.

According to the Canadian Cancer Society, stromal tumors account for roughly 7% of cases of ovarian cancer. They are typically found in females over 50.

Germ cell tumors. These tumors develop from cells that make eggs. They account for 2–3% of cases of ovarian cancer. Women in their teens and 20s are more prone to experience this type of cancer.

A study identifies novel ovarian cancer biomarkers.

The most prevalent type of ovarian cancer, high-grade serous carcinoma (HGSC), was used by the researchers to collect extracellular vesicles (EVs).

To boost cell growth and survival as well as increase invasive and metastatic activities, cancer cells create EVs. Exosomes, a kind of small EV, are crucial to the development of cancer.

The scientists next examined the proteins present in small, medium, and big EVs using liquid chromatography-mass spectrometry.

According to lead author and assistant professor of obstetrics and gynecology at Nagoya University Hospital in Japan, Dr. Akira Yokoi, “The validation steps for the identified proteins were tough because we had to try a lot of antibodies before we found a good target.”

It became evident that the small and medium/large EVs are laden with quite diverse molecules as a result. Small EVs are more suited as biomarkers than medium and large ones, according to further research. The tiny EVs connected to HGSC contained the membrane proteins FR-alpha, Claudin-3, and TACSTD2, he continues.

They had to figure out how to extract the EVs from blood samples after they had discovered the proteins in order to see if they might be utilised to identify ovarian cancer.

The team made use of specialised nanowire technology to collect the EVs. In order to separate exosomes from blood samples, they discovered that polyketone chain-coated nanowires (pNWs) were the best option.

On the nanowires, we must have tested three to four different coatings. Despite being a brand-new substance, polyketones were ultimately a great fit for coating this particular sort of nanowire, according to Dr. Akira Yokoi.

Chance of an earlier diagnosis

The most essential thing we can do to increase survival is probably to diagnose cancer sooner, yet for the majority of tumours, clinicians don’t have access to good diagnostic tools. Later stages of ovarian cancer are significantly more difficult to cure, and the disease’s signs are frequently overlooked, according to Dr. Godfrey.

There is now only one biomarker, Cancer Antigen 125 (CA125), that can be used to diagnose ovarian cancer. Although CA125 has been a key component of ovarian cancer management for the past 40 years in terms of screening, treatment, and follow-up. Also, it hasn’t showed much promise in terms of early detection.

A number of tests may be used by the doctor to make the diagnosis of ovarian cancer if a patient exhibits symptoms that point in that direction. These could involve a transvaginal ultrasound test, a CT scan, or a laparoscopy to look for any growths. Laparoscopy involves making a small incision and inserting a camera into the abdomen.

However, a biopsy, which entails removing a portion of the tumor for laboratory investigation, is the only reliable method of an ovarian cancer diagnosis. A straightforward blood test-based diagnosis approach would be a significant advancement.

Experts urge additional study.

Each of the three novel proteins, according to the study’s authors, may serve as valuable indicators for spotting ovarian cancer at an early stage.

According to Dr. Yokoi, “Our results demonstrated that each of the three identified proteins is useful as a biomarker for HGSCs.” According to the study’s findings, these diagnostic biomarkers may serve as indicators of prognosis for particular treatments.

Dr. Godfrey welcomed the study but emphasised that these were preliminary results.

“It’s too soon to say whether the technology could reliably help us spot ovarian cancer early,” he said. “The research only used a small number of clinical samples.”

He continued, that we need to see more study into these kinds of diagnostic tools. However, if they work, they might make significant improvements to how we treat a range of cancer types.

Summary

Those who are at a high risk of developing ovarian cancer may benefit from screening with ovarian cancer tumor markers. However, a diagnosis cannot be made solely on the basis of blood testing.

Tumour markers for ovarian cancer can be used to monitor disease progression and evaluate the efficacy of treatment.

A 2019 research found that the stage of ovarian cancer at the time of diagnosis is advanced in more than 70% of patients. Although research is ongoing, there is currently no accurate screening method for ovarian cancer.

Knowing the warning signals and informing a doctor of them is crucial for this reason. If you think you have a high chance of developing ovarian cancer, talk to your doctor about the types of testing that could be best for you.

REFERENCES:

For Cancer disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=10

How much protein is generally required to grow muscle?

How much protein is generally required to grow muscle?

Comments 0 Comment

Every cell and tissue in the body has protein. Protein is essential for muscle growth because it helps maintain and repair muscle tissue, in addition to serving many other important functions in the body.

As of right now, mildly active persons should consume 0.8 grams of protein per kilogram of body weight to avoid malnutrition. However, a more recent study indicates that those looking to gain muscle require more than this.

Less protein intake than the body requires has been associated with a reduction in muscle mass. In contrast, when combined with resistance exercise, higher protein consumption than the RDA may aid in boosting strength and lean body mass.

Why is protein necessary for muscular growth?

Amino acids, which make up protein, serve as the building blocks for the body’s cells and tissues. In order to create proteins, 20 amino acids must be combined.

Some substances can be produced by the human body, whereas others cannot. Essential amino acids are the nine amino acids that the body cannot produce on its own. These need to be consumed through food.

When a person eats protein, it is digested and broken down into amino acids, which are crucial for the body’s many functions. This includes energy production, immunological response, and tissue growth and repair.

What amount of protein do you require?

Dietary Guidelines for Americans for 2020–2025 state that the majority of healthy persons over the age of 19 should obtain between 10–35% of their daily calories from protein. 4 calories are contained in one gram of protein.

Accordingly, 50 to 175 grams of protein must be consumed daily by someone who consumes 2,000 calories daily.

Based on the amount needed to keep nitrogen balance and stop muscle loss, the current RDA for protein is 0.8 g per kg of body weight. It might not be suitable to apply these suggestions to muscle-building active people, though.

The optimal daily protein intake a person should consume varies depending on several characteristics, including age, gender, activity level, health, and other considerations.

But we now have a decent notion of how to figure out how much protein an adult needs to gain muscle weight-based on a number of research.

What have studies found?

When paired with resistance exercise, increased protein intakes are linked to gains in lean body mass and strength, according to the majority of research. However, the ideal protein intake for muscle growth is still debatable.

Here are the results of the newest research.

A 2020 meta-analysis indicated that protein intake between 0.5 and 3.5 g per kg of body weight can promote gains in lean body mass. The study was published in the journal Nutrition Reviews. Particularly, researchers found that a small daily increase in protein intake as low as 0.1 grams per kilogram of body weight can assist maintain or build muscle growth.

After 1.3 g of protein per kg of body weight was exceeded, the rate at which lean body mass increased in response to larger protein consumption rapidly dropped. An increase in strength prevented this drop. This implies that the optimum strategy for gaining lean body mass is a higher protein diet combined with strength exercise.

Another meta-analysis from 2022, which was published in the journal Sports Medicine, found that resistance training and increased protein intakes of about 1.5 g per kg of body weight daily are necessary for the best effects on muscle strength. Researchers found that at 1.5 to 1.6 g per kg of body weight per day, the benefits of higher protein intake on strength and muscle mass appear to plateau.

Last but not least, a systematic review and meta-analysis from 2022 found that young, resistance-trained individuals who consume 1.6 g of protein per kg of body weight per day or more see modest gains in lean body mass. Results for people over the age of 60 were meagre.

What are the top sources of protein?

A person can consume both animal and plant-based protein sources to achieve their daily protein requirements.

Sources of animal-based protein include:

  • lean meats, such as lamb, pig, or beef
  • poultry
  • eggs
  • seafood and fish
  • dairy ingredients
  • powdered whey protein.

sources of plant-based protein include:

  • beans
  • peas
  • nuts
  • lentils
  • seeds
  • soy-based goods
  • powders made of plant protein.

When it comes to gaining muscle mass, some nutritionists believe that animal protein sources are superior to plant-based protein sources. This is due to the fact that they sufficiently contain all of the essential amino acids the body requires. Moreover, they are simple to digest.

Some plant-based proteins are more difficult to digest and less bioavailable. Additionally, the profiles of their amino acids vary. But those who choose plant-based diets can easily make up the difference by consuming more protein overall and choosing a range of foods.

People can pair foods like rice and beans, hummus with pita bread, or peanut butter on whole wheat bread to get all the essential amino acids in a plant-based diet.

Soy is one notable exception, as it is highly bioavailable, has an excellent amino acid profile, and is simple to digest.

When is too much protein too much?

According to most medical professionals, healthy persons may sustain a long-term protein intake of up to 2 g per kg of body weight per day without experiencing any negative side effects. Athletes who are in good health and have received proper training, for example, may endure up to 3.5 g per kg of body weight.

The majority of research indicates that consuming more than 2 g of protein per kg of body weight per day may eventually lead to health problems.

Potential dangers

Symptoms of consuming too much protein include:

  • diarrheal discomfort
  • nausea
  • dehydration
  • fatigue
  • gaining weight
  • irritation
  • headache.

Chronic protein overconsumption has more serious dangers, such as:

Protein intakes over the recommended daily allowance (RDA) can support muscle growth when paired with resistance training.

Lean meat, fish, beans, nuts, and legumes are the healthiest food choices to help you achieve your daily protein requirements.

Since the ideal protein intake for an individual depends on age, health, and activity level, you might want to consult a qualified dietitian or a healthcare professional to find out how much protein is right for you.

REFERENCES:

For Muscle medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=28

Do reading and puzzle-solving fade away dementia?

Do reading and puzzle-solving fade away dementia?

Comments 0 Comment

Dementia is a chronic neurological disease that affects memory and thought processes and affects millions of individuals worldwide. The most prevalent type of dementia is Alzheimer’s.

There are various medications available to help manage dementia symptoms, but there is no known treatment for the illness.

Significant research is being done to find out more about the pathophysiology of dementia and to create therapies, but it is also being done to find out how lifestyle changes may affect dementia risk and cognition.

This study looks at the effects of reading and crossword puzzles and other cognitively stimulating activities on dementia risk and cognition.

High levels of cognitive activity, such as reading, playing games like checkers and puzzles, and writing letters, can delay the start of Alzheimer’s disease by five years in those 80 years and older, according to a study published in Neurology in 2021.

Another study indicated that more time spent engaging in cognitively passive activities, like watching TV, is associated with an increased risk of dementia, whereas more time engaged in cognitively active activities, like using a computer, is associated with a decreased risk of dementia.

Five experts were interviewed to learn more about themes such as how cognitively stimulating activities lower the risk of dementia, what else lowers the risk of dementia, and what action should be taken in light of the research.

Engaging pursuits increase mental capacity

Dr. Joyce Gomes-Osman, vice president of interventional therapy at Linus Health and a volunteer assistant professor of neurology at the University of Miami Miller School of Medicine, was the first person the experts spoke with.

She claimed that engaging in intellectually demanding activities, like reading and crossword puzzles, increases one’s cognitive reserve, which she compared to the amount of one’s mental library and lowers the chance of developing dementia, and improves cognition.

Every knowledge we acquire is like a book on a shelf. The library keeps expanding as more books are added. You might wonder why this matters, though. Building a library of knowledge in your brain, then, acts as a buffer against memory loss, she explained.

She said, “When your library is large, even if many volumes are checked out, there will still be plenty of other books on the shelves, serving as alternatives and maintaining the library in good condition.”

She outlined how education and experiences in life, particularly those that are difficult and require thought, help people grow their cognitive reserves over the course of their lives.

Research

Researchers looked into the effects of early cognitive development, educational attainment, and leisure activities on cognitive reserve in a recent study that was published in 2022 in Neurology.

From their early years up until the age of 69, they monitored 1,184 persons from the United Kingdom. At that age, the participants underwent a cognitive test with a possible score of 100.

Ultimately, the researchers discovered that those with a bachelor’s degree or more typically scored 1.22 points higher than those with no formal schooling. In comparison to individuals who participated in only four of these activities, those who participated in six or more leisure activities such as educational classes, volunteer work, and social activities scored an average of 1.53 points more.

Meanwhile, those with professional or intermediate-level jobs outperformed those with partially skilled or unskilled jobs by 1.5 points or more on average. Additionally, they discovered that those with better reading skills exhibited a slower rate of cognitive deterioration than those with worse reading skills.

The brain is exercised in several ways during mental exercises.

Dr. David Hunter, an assistant professor of neurology at McGovern Medical School at UTHealth Houston, was also interviewed by experts. Research, he said, has shown that even people with advanced dementia can benefit from what he refers to as “mental exercise”—anything that simultaneously stimulates various sections of the brain.

Just a few examples are reading, crosswords, painting, conversation, gaming, and work. The sole restriction, in reality, is that watching TV all day doesn’t count.

He noted that if patients are unable to engage in their previous interests, other options include colouring books, music, word searches, and simple chat.

Does the cognitive reserve have a limit?

Even if specialists concur that a person’s cognitive reserve is crucial in assisting them in maintaining their thinking abilities, they also point out that there are limits to how much we can improve this reserve through “mental exercises.”

Raphael Wald, a board-certified neuropsychologist with a doctorate in psychology from Baptist Health Marcus Neuroscience Institute, stated to experts:

“Because they have more cognitive reserve, people with high IQs typically fare better with dementia”. However, once dementia has developed, cognitive activities like crossword puzzles cannot stop the degenerative process. But it might make things go more slowly.

We also had a conversation with Dr. Karen D. Lincoln, a professor at the University of California, Irvine’s Department of Environmental and Occupational Health.

While some research indicates that mental workouts like crossword puzzles or word games reduce cognitive deterioration in those with mild cognitive impairment, the research is still ambiguous, she observed.

Puzzles alone may not always enhance cognitive ability or reduce the incidence of dementia, but these kinds of mental tasks are crucial for brain stimulation. Instead of breaking our circulatory system down into discrete sections, we must take it all into account.

Dr. Gomes-Osman concurred that focusing just on mentally stimulating activities is insufficient for lowering the risk of dementia. She pointed out that the “cutting-edge” research in the subject demonstrates that various healthy behaviours are most effective at reducing dementia risk and improving thinking abilities.

What are the 12 modifiable dementia risk factors?

Dr. Gomes-Osman used the Lancet Commission’s 2020 report on dementia prevention, intervention, and care when discussing which behaviours to focus on.

The study identified 12 risk factors for dementia, which together account for 40% of dementia cases.

  • The education level of a person
  • their degree of interpersonal ties
  • unsound hearing
  • workout regimen
  • depression indications
  • using alcohol
  • adult obesity
  • pollution from the air exposure
  • smoking customs
  • head trauma
  • High blood pressure, or hypertension
  • diabetes

According to the report’s authors, addressing these factors can lower the risk of dementia by lowering neuropathological damage. This includes accumulation of tau protein and inflammation, and by either boosting or maintaining cognitive reserve.

Dr. Gomes-Osman stated, “Just to give you an idea, if we all took these steps today, we would reduce dementia cases by over a third next year.”

How to lower the risk of dementia?

It’s crucial to stress that learning something new can strengthen your brain even if you’re already suffering from memory loss. Learning something new will sharpen your memory, focus, and thinking processes while also enhancing your quality of life, according to Dr. Gomes-Osman.

She continued by saying that having fresh, joyful experiences and taking in new sights could both benefit brain function.

Picking something that is neither too easy nor too difficult is crucial in this situation since our brains respond positively to novelty, she explained.

“Change the place where you perform your favorite activities. Going to new areas can boost your outlook on life and strengthen your brain“, according to Dr. Gomes-Osman.

Try walking somewhere new if you typically go for a walk, for instance. Additionally, you might choose a different route to get to work or a different grocery store. Even locating the milk aisle in several stores will need you to use creative problem-solving techniques. Don’t let a day pass without getting out and seeing something new, advised Dr. Joyce Gomes-Osman.

“A special note for African Americans,” Dr. Lincoln said, “who have the highest risk of dementia and Alzheimer’s disease in the United States.”

If you enjoy playing bid whist, dominoes, or spades, you are truly exercising your brain, he claimed. “The games are played with others, not necessarily because they are difficult or need good recall. Social interaction benefits the brain.

REFERENCES:

For Mental disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=77_478

How bacteria can occupy the skin and elevate eczema growth?

How bacteria can occupy the skin and elevate eczema growth?

Comments 0 Comment

Researchers looked into how bacteria might impact the histology of eczema in a recent study. They claimed that S. aureus bacteria change in eczema patches, speeding up their spread.

Eczema, the most prevalent type of atopic dermatitis, is an itchy, dry skin condition that is not communicable. In the US, 30% of the population is affected by the illness.

Although there is no known cure for eczema, there are drugs available to treat its symptoms. These include topical emollients, topical immunosuppressants, and topical corticosteroids.

Eczema is believed to result from a combination of hereditary and environmental factors. A flare-up of eczema may occur when the immune system is triggered by irritants found in soaps and surface cleansers, for instance.

Variants in the gene that makes the protein filaggrin may cause lower production in eczema patients. Filaggrin is crucial for boosting skin elasticity.

People who have eczema may have breaks in their skin, which bacteria can enter and develop in. The immune system may try to stop this colonization by escalating the inflammation, which aggravates the itching and further damages the skin.

The creation of new medications to treat eczema may be aided by knowing more about how germs grow into eczema sufferers’ skin and how it causes inflammation.

Recent studies looked into how Staphylococcus aureus adjusts to the skin of eczema sufferers. They claimed that the bacteria undergo alterations that cause them to lose their cellular capsule, allowing them to grow more quickly on the skin.

Dr. Alain Michon, the medical director of Project Skin MD Ottawa in Canada and a non-participant in the study, was consulted by specialists over the results.

What kind of bacteria is S. aureus?

According to earlier studies, S. aureus can frequently be found on the skin of eczema sufferers. Their eczema tends to be more severe the more bacteria they have.

By secreting toxins and drawing in immune cells, S. aureus is hypothesised to contribute to the pathophysiology of eczema and worsen the condition of the skin barrier.

S. Aureus is present in the nasal passages of up to 30% of persons. While the majority of infections are not serious, they can result in pneumonia, bone and joint infections, and serious bloodstream infections.

Information from the study on bacteria and eczema

The 23 children in Mexico between the ages of 5 and 15 who had moderate to severe eczema were the subjects of this longitudinal study by the researchers.

Standard medical care, such as topical steroids, emollient moisturisers, and bleach baths, were given to all of the subjects.

The children’s skin microorganisms were sampled by the researchers once per month for three months, and then again at nine months. Samples were collected from common eczema-affected areas such as the inside of the elbows and the backs of the knees. Additionally, they collected samples from the noses and forearms, which are often unaffected by the bacterium.

After that, the scientists cultivated S. aureus cells from every location, producing nearly 1,500 different colonies. This allowed them to more closely track the evolution of the certain cells.

At the end of the trial, they discovered that the majority of participants had only one lineage of S. aureus, indicating that new strains did not develop over time from the environment or other participants. However, they observed that throughout the trial, each lineage underwent significant mutation.

A gene called caps, which codes for an enzyme required for synthesizing polysaccharide a capsule-like shell that protects S. aureus from immune cells suffered several changes that lowered or abolished function, the researchers found in particular.

In a third of the subjects, the researchers discovered that capD mutations completely dominated the S. aureus microbiome population over the course of the study.

The researchers initially identified four distinct capD mutations in one youngster. By the time the trial was through, one of the variations had taken over and had expanded throughout the entire microbiome.

Increased eczema immunodetection

Dr. J. Wes Ulm of the National Institutes of Health, who was not involved in the study, was interviewed by Medical News Today about how mutations that make S. aureus more detectable by the immune system increase the spread of the bacteria and eczema on the skin.

Ulm remarked that from some angles, S. aureus becoming more readily identifiable by the immune system could appear to be a drawback. But he went on to say that if capD expression is lost or reduced, the bacteria may be better able to grow and spread since the energy that would have been used to create a useful capsule can now be used to fuel development.

Additionally, the absence of a capsule would make it simpler for the bacterium to adhere to the skin’s surface, improving its ability to spread throughout the skin.

Its lack of capD makes it easier for the immune system to detect and target the capD-deficient strain when it becomes more prevalent on the [skin’s] microbiome, Ulm said. Consequently, “and this, in turn, can enhance the immune response and magnify the inflammatory reaction giving rise to the characteristic rash and symptoms of eczema.”

Problems with the eczema research

The study’s tiny sample size, according to Michon, limits how broadly these results may be applied to other populations.

The results, he continued, might have been impacted by the fact that certain individuals’ microbiomes may have changed among those who took antibiotics both before and during the trial.

Other restrictions were also mentioned by Cameron K. Rokhsar, FAAD FAACS, a dermatologist and fellowship-trained cosmetic and laser surgeon in Manhattan and Long Island, New York, who was not associated with the study.

The drawback of these discoveries, according to Rokhsar, is that bacterial overgrowth only accounts for a portion of the overall puzzle. “The malfunctioning barrier specific to these people is the real problem with atopic dermatitis. Antibiotics are given to patients to reduce atopic dermatitis flare-ups, but they do not treat eczema.

REFERENCES:

For Skin disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=27

Importance of Intense exercise for Parkinson’s symptoms.

Importance of Intense exercise for Parkinson’s symptoms.

Comments 0 Comment

According to a recent study, vigorous exercise may help reduce the progression of Parkinson’s disease.

Nearly 90,000 people in the United States receive a new diagnosis of Parkinson’s disease each year. The second most prevalent neurological disease worldwide is Parkinson’s.

Recent findings from an international team of researchers suggest that a vigorous exercise regimen may possibly halt the progression of Parkinson’s disease, opening the door for non-pharmaceutical methods of relieving symptoms and treating the condition.

According to the Parkinson’s Foundation, almost 90,000 people in the United States receive a new diagnosis of Parkinson’s disease each year. Right now, there is no remedy.

Clinical researchers from all over the world are working to manage symptoms and better understand how to do so in addition to trying to find a cure.

Parkinson’s disease, which has been afflicting people for many years, is the second most prevalent neurological ailment in the world after Alzheimer’s disease.

However, because many of the symptoms appear years after the damage begins, it can be challenging to understand this disorder in its early stages.

This rat study looked at whether strenuous exercise could alter the brain abnormalities shown in a Parkinson’s disease experiment.

Physical activity and Parkinson’s

Data showing that vigorous exercise reduces both the motor and cognitive symptoms connected with Parkinson’s disease were published on July 14 in the journal Science Advances by a team of neuroscientists from the Faculty of Medicine of the Catholic University, Rome Campus with the A. Gemelli IRCCS Polyclinic Foundation.

They have gained a better understanding of how this works thanks to their research.

As a neurologist treating Parkinson’s disease patients in the early stages, Paolo Calabresi, Full Professor of Neurology in the Department of Neuroscience at Catholic University of the Sacred Heart in Rome, Italy, said: “I noticed that some of them had a better course of the disease when they were routinely actively doing aerobic exercise.”

How is exercising beneficial?

Exercise, according to experts, is essential to sustaining a healthy lifestyle in general. They also think it can lessen some of the more noticeable symptoms of some illnesses, like Parkinson’s.

Tremors, a shuffling stride, and general slowness of physical movement are some of the early signs of Parkinson’s disease. Harvard Health Letter claims that one of the best methods to treat the illness is through exercise.

How does it assist?

It has been demonstrated that physical activity increases the production of neurotrophic factors including brain-derived neurotrophic factor (BDNF). These elements are essential for the development, maintenance, and survival of neurons. These are essential for the development of new neurons, the preservation of existing neurons, and the improvement of synaptic connections, according to Jennifer Prescott, RN, MSN, CDP, the study’s lead author.

Exercise has been demonstrated to enhance mitochondrial function and encourage mitochondrial biogenesis. For the generation of energy and overall brain health, healthy mitochondria are essential, according to Prescott.

Dr. Daniel Truong, a neurologist and the medical director of The Parkinson’s and Movement Disorder Institute at MemorialCare Orange Coast Medical Centre in California, claims that there are more ways exercise benefits people with Parkinson’s disease.

For us, Truong provided the following examples:

Reduced Alpha-Synuclein Aggregates: The spread of pathogenic alpha-synuclein aggregates in the brain is inhibited by intense exercise. These aggregates, which are a defining feature of Parkinson’s disease, cause neuronal malfunction and death.

Exercise May Help Preserve Motor Control and Visuospatial Learning: According to research, Parkinson’s disease frequently results in a decline in motor control and visuospatial learning because of the degradation of particular brain regions (the substantia nigra pars compacta and the striatum).

The study found that the neurotransmitter glutamate, which is important in learning and memory, interacts with the NMDA receptor for BDNF, whose levels rise with exercise. Through this interaction, neurons in the striatum can react to stimuli more quickly, which offers advantages that go beyond exercise practice.

Exercise has been shown to have anti-inflammatory effects, which may help treat Parkinson’s disease.

Which workouts are most beneficial for Parkinson’s disease

Dr. Andrew Feigin, the executive director of the Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders at NYU Langone Health in New York stated that regular exercise helps maintain motor function in [Parkinson’s] patients and may reduce the advancement of the disease.

“We frequently advise all of our Parkinson’s patients to engage in regular exercise. However, we do urge activity,” Feigin said. “Of course, patients have varying capacities for exercise depending on a variety of things, including the severity of Parkinson’s.

“In the past, exercise advice might have been ambiguous, such as ‘taking a walk occasionally. With a better understanding of the advantages of exercise, we are offering more specific advice: this study and others that came before it emphasizes the need for high-intensity exercise, with earlier research suggesting that this intensity should achieve 80 to 85 percent of maximum heart rate for 30 minutes, three to four times per week.

Power walking, swimming, water aerobics, exercise cycles, and other activities with little to no impact but high intensity are frequently recommended to patients, said Petrossian. Additionally, in line with earlier studies, we suggested strength training twice a week using progressive resistance exercises with heavier weights or repetitions. Additionally, we offer our patients advice on stretching, balance training, core strengthening, and skill-based exercises like Pilates, yoga, dance, boxing, and ping pong.

“Exercise can help reduce the symptoms of [Parkinson’s] in the short term, improve energy, lengthen strides and balance, prevent falls, improve sleep and mood, and improve cognition,” she added. In addition to the recent study indicating decreased alpha-synuclein propagation, BDNF release is neuroprotective. Through angiogenesis, exercise can also increase cerebral blood flow.

In advanced Parkinson’s disease, exercise can help

The researchers examined exercise in the new trial and found distinct and significant advantages when the disease was in its early stages.

According to experts, exercise may also be advantageous later on and have other goals.

“In the later stages of Parkinson’s disease, the primary benefits of exercise could potentially shift towards the maintenance of mobility, strength, balance, and flexibility, as well as improvement in quality of life,” added Truong. “As we all know, exercise can help control symptoms like constipation and can also enhance mood and sleep. Falls are less likely when you exercise your balance.

Truong stated that it’s crucial to keep in mind that patients with Parkinson’s disease in its latter stages frequently experience more severe symptoms and may have additional medical problems. “Therefore, any exercise programme must be carefully designed to ensure safety and effectiveness for the individual’s specific condition and needs.”

Summary

Intense exercise may help people with Parkinson’s disease lessen their symptoms, according to a recent study. Exercise preserved the aggregates that cause Parkinson’s disease and prevented their spread, according to research done on rats. They discovered that exercise reduced the symptoms and slowed the disease’s progress as a result.

REFERENCES:

For Parkinson’s disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=64